Latest News

Ford Motor has overhauled its electrification roadmap, halting several larger EV programs, ending the current F‑150 Lightning, and recording about US$19.50 billion in special charges tied to refocusing on affordable EVs, hybrids and a new battery energy storage business. This reset shifts capital toward higher-return trucks, vans and a flexible Universal EV Platform, while Ford assumes about US$3.00 billion in pre-tax charges to take full control of two Kentucky battery plants from its...

Wondering if HNI is quietly turning into a value opportunity while most investors are looking elsewhere? Here is a look at what the market might be missing. HNI's share price has ticked up about 2.0% over the last week and 6.0% over the last month, even though it is still down 15.9% year to date and 20.8% over the last year. Zooming out, the stock is up 70.3% over 3 years and 41.6% over 5 years, which may point to a longer term recovery story beneath the recent weakness. Recent headlines...

Fiserv (FISV) is back in the spotlight after a wave of cautious analyst updates and investor letters questioning its turnaround story, even as fresh product integrations and long term growth plans continue moving forward. See our latest analysis for Fiserv. The latest integration wins and cautious analyst commentary are playing out against a sharp reset in expectations. Fiserv’s 30 day share price return of 8.75% offers a tentative bounce after a year to date share price decline of 66.52% and...

Wolters Kluwer (ENXTAM:WKL) just put its Expert AI front and center with the upcoming launch of CCH Axcess Advisor, a platform built to nudge accounting firms toward recurring advisory relationships. See our latest analysis for Wolters Kluwer. These Expert AI launches come as Wolters Kluwer’s share price, now around $90.5, shows pressure, with a year to date share price return of minus 43.9 percent and a five year total shareholder return still positive at about 42.4 percent. This suggests...

Pandora (CPSE:PNDORA) is back in focus after the board accelerated its leadership transition, moving Berta de Pablos-Barbier into the CEO seat earlier than planned. This shift could subtly reshape the jewelry maker’s strategy. See our latest analysis for Pandora. The leadership shake up is landing against a tough backdrop, with a roughly 46 percent year to date share price return in negative territory and a 42 percent negative total shareholder return over 12 months. However, the three year...

Box (BOX) has slipped over the past month and quarter, even as its long term performance remains solid. That pullback has investors asking whether the current valuation fairly reflects its growth profile. See our latest analysis for Box. Over the past year, Box’s share price return has drifted lower, with the recent 7 day and 30 day share price returns both negative, even though the 5 year total shareholder return remains meaningfully positive. This suggests momentum has cooled while the long...

Rocket Lab (RKLB) just checked two big boxes for investors, qualifying its world first reusable Neutron fairing and successfully flying JAXA’s dedicated RAISE And Shine mission, together strengthening its case for higher margin, repeat business. See our latest analysis for Rocket Lab. The latest pullback, with a roughly 9.9% one day share price return decline after the JAXA success, looks more like profit taking than a change in thesis. This is especially the case given Rocket Lab’s triple...

In early December 2025, Las Vegas Sands drew attention as Chairman and CEO Robert G. Goldstein sold about US$26.6 million of stock after exercising options, while the company also presented at Macquarie’s Asia Conference 2025 in New York. Analyst sentiment turned more constructive as Goldman Sachs upgraded Las Vegas Sands to Buy, reflecting growing confidence in the company’s Singapore and Macau-focused operations despite recent insider selling. With Goldman Sachs’ upgrade highlighting...

Earlier this week, CNA Financial moved after the Federal Reserve cut its benchmark interest rate by 25 basis points to a range of 3.5%–3.75%, with Chair Jerome Powell’s comments easing concerns about tighter policy ahead. The reaction underscored how closely investors link CNA Financial’s prospects to shifts in monetary policy, given the company’s reliance on investment income and broader market conditions. We’ll now examine how the Fed’s interest rate cut, and its effect on expectations for...

Stock performance snapshot Novo Nordisk (NYSE:NVO) shares have quietly rebounded about 8% over the past week, trimming some of this year’s heavy slide. As a result, some investors are asking whether the pullback has finally gone too far. See our latest analysis for Novo Nordisk. Even after this latest bounce, Novo Nordisk’s 90 day share price return of negative 11.9 percent and one year total shareholder return of negative 52.5 percent show that momentum has been fading, despite ongoing...

Wondering if Pembina Pipeline is still a smart buy at today’s price, or if most of the upside has already been baked in? Let us unpack what the market is really paying for here. The stock has drifted slightly lower in the short term, down 2.8% over the last week and 2.5% over the last month. It is still up 5.4% over the past year, 39.0% over three years, and 130.4% over five years, which hints at a long runway of value creation despite recent softness. Recent headlines have focused on...

ASX (ASX:ASX) is back in focus after ASIC hit the exchange operator with an extra A$150 million capital charge, which is tied to a sweeping governance and risk management overhaul. See our latest analysis for ASX. The latest ASIC action has come on top of a tough run for the stock, with a 1 year total shareholder return of around negative 20 percent and a deeply negative year to date share price return, signaling fading momentum as investors reprice governance and execution risks. If this...

Vaxcyte (PCVX) just crossed a major clinical milestone by dosing the first participants in its OPUS Phase 3 trial for VAX-31, a next generation pneumococcal vaccine candidate aligned with FDA expectations. See our latest analysis for Vaxcyte. The OPUS Phase 3 start comes after a volatile stretch, with the latest share price at $44.34 and a roughly 44% 3 month share price return contrasting with a much weaker 1 year total shareholder return. This suggests near term momentum is rebuilding as...

CenterPoint Energy’s board previously declared a regular quarterly cash dividend of US$0.23 per share, payable on March 12, 2026, to shareholders of record on February 19, 2026, while the company also joined Palantir’s new Chain Reaction AI infrastructure platform as a founding partner alongside NVIDIA. This combination of a higher cash return to shareholders and early involvement in AI-driven power infrastructure software highlights how CenterPoint is balancing traditional utility income...

On December 3, 2025, American Financial Group increased its equity buyback authorization by 5,000,000 shares to a total of 57,188,938 shares and extended the program through December 31, 2030. This larger and longer buyback plan highlights management’s capital-return priorities and may gradually reshape the company’s ownership base over time. We’ll now examine how AFG’s enlarged, longer-dated buyback authorization could influence its existing investment narrative around earnings growth and...

fuboTV (FUBO) has been grinding lower recently, with the stock down around 29% over the past month and about 40% in the past 3 months, despite revenue growing roughly 30% annually. See our latest analysis for fuboTV. Zooming out, that recent slide comes after a sharp rally, with the year to date share price return still strong and the one year total shareholder return comfortably positive. This suggests momentum has cooled rather than completely reversed as investors reassess execution risk...

Wondering if Hilton Worldwide Holdings is still a smart buy after its huge run, or if the easy money has already been made? You are not alone. The stock has climbed 5.9% over the last week, 6.0% over the past month and is now up 16.6% year to date, adding to an already impressive 178.3% gain over five years. Part of this strength reflects steady optimism around global travel demand and Hilton's capital-light, fee-based model that investors increasingly see as structurally attractive. At the...

Integral Ad Science Holding (IAS) has been quietly grinding higher, with shares up about 22% over the past 3 months as investors reappraise its role in ad verification and connected TV. See our latest analysis for Integral Ad Science Holding. That recent 22% 3 month share price return has helped repair some of the damage from a softer year to date and slightly negative 1 year total shareholder return, suggesting momentum is quietly rebuilding as investors reassess growth and risk. If IAS has...

Wondering if Enphase Energy is a beaten down gem or a value trap at today’s price? This article will walk you through what the numbers are really saying about the stock. The share price has slipped 0.6% over the last week, bounced 9.4% over the past month, but is still down a steep 56.0% year to date and 57.3% over the last year, with even deeper losses over 3 and 5 years. Those swings have come as investors reassess solar and clean energy names more broadly, with shifting sentiment around...

V.F (VFC) has been quietly climbing, with the stock up roughly 29% over the past month and 31% in the past 3 months, even as its longer term returns remain weak. See our latest analysis for V.F. Even after this short term rally, with the share price at $19.27, V.F still has a negative year to date share price return and a deeply negative five year total shareholder return. As a result, the recent momentum looks more like an early sentiment shift than a full comeback. If V.F’s rebound has you...

Trulieve Cannabis (CNSX:TRUL) just overhauled its balance sheet by redeeming its 2026 senior secured notes and lining up a new 10.5% 2030 debt deal, and investors are reassessing the stock. See our latest analysis for Trulieve Cannabis. The refinancing news comes on the back of a sharp turnaround in sentiment, with a 7 day share price return of about 61 percent and a 30 day share price return near 75 percent. However, the 5 year total shareholder return is still deeply negative, suggesting...

In early December 2025, investor law firm Schall Law Firm announced an investigation into Nutex Health over potential securities law violations linked to a short-seller report alleging improper billing practices and an undisclosed ‘mystery consultant’ relationship. This scrutiny adds legal and governance risk to Nutex Health’s story at a time when its business model already relies heavily on complex reimbursement and arbitration processes. We’ll now examine how the securities investigation...

goeasy (TSX:GSY) is back in focus after announcing a major leadership change, with current CEO Dan Rees set to step down at year end and easyfinancial president Patrick Ens stepping into the top job. See our latest analysis for goeasy. That backdrop helps explain why the stock has been choppy recently, with a sharp 90 day share price return of around negative 39 percent pulling year to date performance lower. Even so, the five year total shareholder return remains solidly positive, suggesting...

If you have been wondering whether Constellation Energy is still worth buying after its huge run, you are not alone. This breakdown will help you decide if the current price still stacks up to its fundamentals. The stock has slipped about 0.6% over the last week but is still up 5.5% over the past month, 47.2% year to date, and 53.3% over the last year, with a 318.0% gain over three years reshaping expectations around its growth and risk profile. Investors have been reacting to Constellation...